Lautan Luas Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Lautan Luas Tbk. trades at Rp780 (market cap 1.19T, 2.2K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp248 (market cap 167.37B, 96.7K 24h volume). The key difference: Lautan Luas Tbk. is far larger — about 7.1× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (96.7K versus 2.2K). Which is the better fit depends on your goals.
| LTLS | OBAT | |
|---|---|---|
Market Cap | 1.19T | 167.37B |
Volume | 2.2K | 96.7K |
Lot | 22 | 967 |
Turnover | 1.68M | 23.82M |
Average Price | 765 | 246.34 |
Value | 1.68M | 23.82M |
Indicative Equilibrium Price | 780 | 248 |
Indicative Equilibrium Volume | 1 | 41 |
Trailing returns across standard periods
Latest headlines on both assets
PT Lautan Luas Tbk (the Company) was established under the name of Persekutuan Andil Maskapai Dagang dan Industri Lim Teck Lee Coy Ltd (Indonesia) based on notarial deed No. 75 dated January 18, 1951 of Raden Mas Soerojo. PT. Lautan Luas is a distributor and manufacturer - specialty and basic chemical.
Read more on LTLS →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →